COMy 2019 | Is there potential to reduce the cost of myeloma therapy?
Vincent Rajkumar
• 17 May 2019
Here, Vincent Rajkumar, MD, of the Mayo Clinic, Rochester, MN, discusses the high costs of multiple myeloma therapy, even in developed countries. Dr Rajkumar highlights the need for further studies into the optimal length of maintenance therapy, which could help to reduce costs as well as minimizing toxicity and the risk of secondary malignancies. This interview was recorded at the Controversies in Multiple Myeloma (COMy) 2019 meeting held in Paris, France.
